2012 Chrysler 200 Lx on 2040-cars
8315 E Us Highway 36, Avon, Indiana, United States
Engine:2.4L I4 16V MPFI DOHC
Transmission:Automatic
VIN (Vehicle Identification Number): 1C3CCBAB3CN320490
Stock Num: B30540
Make: Chrysler
Model: 200 LX
Year: 2012
Exterior Color: Bright White
Interior Color: Black
Options: Drive Type: FWD
Number of Doors: 4 Doors
Mileage: 35584
TEXT US @888-903-0491 This Chrysler 200 LX is in great condition both inside and out. No abnormal wear and tear. This finely crafted vehicle is engineered to last. But just in case it doesn't, you can take comfort knowing it comes with a manufacturer's warranty. This Chrysler includes: BRIGHT WHITE 2.4L DOHC SMPI 16-VALVE I4 DUAL VVT ENGINE (STD) More information about the 2012 Chrysler 200: The 2012 Chrysler 200 offers much to like for buyers interested in a stylish, economical, and inexpensive mid-size sedan. Things like a 283-hp V6, a true 4-seat convertible, and still inexpensive prices mean that power- and luxury-seekers on a budget can have theirs, too. Entry price is below $19,000 and that buys plenty of car. Strengths of this model include convertible availability, good V6 power, Fuel economy, and low price of entry Ask about our Out-of-State Package Specials History Reports Available at http://www.bartscarstore.com Go to http://www.bartscarstore.com for REAL walk-around video of this vehicle! Transfer this vehicle to any of our 6 locations "Use your SMARTS and buy at BART'S"
Chrysler 200 Series for Sale
2013 chrysler 200 limited(US $27,178.00)
2015 chrysler 200 c(US $32,125.00)
2013 chrysler 200 touring(US $20,991.00)
2013 chrysler 200 touring(US $21,847.00)
2015 chrysler 200 s(US $29,690.00)
2013 chrysler 200 touring(US $20,946.00)
Auto Services in Indiana
Xtreme Precision ★★★★★
Whetsel`s Automotive ★★★★★
USA Auto Mart ★★★★★
Tony Kinser Body Shop ★★★★★
Tire Barn Warehouse ★★★★★
The Tire Store ★★★★★
Auto blog
Fiat Chrysler says it did not know about Marchionne's illness
Fri, Jul 27 2018ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.
Maserati's new North American CEO is Chrysler's dealer guru
Wed, 13 Nov 2013There's been a bit of a shakeup among the executive ranks at Chrysler and Maserati, as the Italian sports car manufacturer has appointed Peter Grady as its new North American CEO. Grady, who we imagine is about to get a very nice upgrade to his company car, will retain his role as vice president of dealer network development for Chrysler and Chrysler Capital, and is replacing Bob Graczyk at Maserati.
"It is with pleasure and anticipation that I welcome Peter to Maserati. He brings to our company nearly 30 years of leadership and experience. His background and industry expertise will be a great basis for the continued expansion of Maserati in North America," said Maserati CEO Harald Wester in a statement.
Also joining the team at Maserati is Saad Chehab, who previously worked for the Chrysler and Lancia brands and will be the new head of marketing for the Italian brand. He'll be replaced by Al Gardner, the former boss of Chrysler's southeast business center, as the head of Chrysler brand, according to Automotive News.
EIB ups financing for Fiat Chrysler's electric vehicles to $949 million
Sat, Sep 19 2020MILAN — The European Investment Bank (EIB) has increased to almost 800 million euros ($949 million) its funding to Fiat Chrysler Automobiles (FCA) to support production of electric and hybrid vehicles, they said in a joint statement. Investments to manufacture battery electric vehicles and plug-in hybrid electric vehicles will be mainly directed at FCA plants located in southern Italy, supporting employment and compliance with the strictest environmental criteria. To improve capacity utilization at FCA's Italian plants, the group has announced a 5 billion euro investment plan for the country through 2021 which envisages the launch of new electric and hybrid models. EIB and FCA had sealed 300 million euros in financing before the summer to fund investments for plug-in hybrid electric vehicle production lines at plants in Melfi, in the southern Basilicata region, and battery electric vehicles at Fiat's historic Turin plant of Mirafiori over the 2019-2021 period. FCA has now finalized a 485 million euro deal with EIB to support both an innovative line of plug-in hybrid electric vehicles at the Pomigliano plant in the southern Campania region as well as R&D activities at FCA laboratories in Turin. The EIB credit line covers 75% of the total value of FCA's investment in the project for the 2020-2023 period. Earnings/Financials Green Plants/Manufacturing Chrysler Fiat






















